Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Laila Jacobsson

Laila Jacobsson

Laboratory engineer

Laila Jacobsson

Cartilage oligomeric matrix protein promotes prostate cancer progression by enhancing invasion and disrupting intracellular calcium homeostasis

Author

  • Emelie Englund
  • Giacomo Canesin
  • Konstantinos S. Papadakos
  • Neelanjan Vishnu
  • Emma Persson
  • Bart Reitsma
  • Aseem Anand
  • Laila Jacobsson
  • Leszek Helczynski
  • Hindrik Mulder
  • Anders Bjartell
  • Anna M. Blom

Summary, in English

Cartilage oligomeric matrix protein (COMP) was recently implicated in the progression of breast cancer. Immunostaining of 342 prostate cancer specimens in tissue microarrays showed that COMP expression is not breast cancer-specific but also occurs in prostate cancer. The expression of COMP in prostate cancer cells correlated with a more aggressive disease with faster recurrence. Subcutaneous xenografts in immunodeficient mice showed that the prostate cancer cell line DU145 overexpressing COMP formed larger tumors in vivo as compared to mock-transfected cells. Purified COMP bound to and enhanced the invasion of DU145 cells in vitro in an integrin-dependent manner. In addition, intracellular COMP expression interfered with cellular metabolism by causing a decreased level of oxidative phosphorylation with a concurrent upregulation of lactate production (Warburg effect). Further, expression of COMP protected cells from induction of apoptosis via several pathways. The effect of COMP on metabolism and apoptosis induction was dependent on the ability of COMP to disrupt intracellular Ca2+ signalling by preventing Ca2+ release from the endoplasmic reticulum. In conclusion, COMP is a potent driver of the progression of prostate cancer, acting in an anti-apoptotic fashion by interfering with the Ca2+ homeostasis of cancer cells.

Department/s

  • Division of Translational Cancer Research
  • Cancer and matrix remodelling
  • Urological cancer, Malmö
  • Protein Chemistry, Malmö
  • Diabetes - Molecular Metabolism
  • Department of Translational Medicine
  • BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
  • EpiHealth: Epidemiology for Health

Publishing year

2017

Language

English

Pages

98298-98311

Publication/Series

Oncotarget

Volume

8

Issue

58

Document type

Journal article

Publisher

Impact Journals, LLC

Topic

  • Medicinal Chemistry
  • Cancer and Oncology

Keywords

  • Apoptosis
  • Ca signalling
  • Cancer progression
  • Metabolism
  • Prostate cancer

Status

Published

Research group

  • Cancer and matrix remodelling
  • Urological cancer, Malmö
  • Protein Chemistry, Malmö
  • Diabetes - Molecular Metabolism

ISBN/ISSN/Other

  • ISSN: 1949-2553